DOI: 10.1055/s-00000030

Der Klinikarzt

References

Harrison C, Kiladijan JJ, Al-Ali HK et al.
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

N Engl J Med 2012;
366: 787-798

Download Bibliographical Data

Search in:
Access: